Melasma. Chloasma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Women 18 to 50 years old with symmetrical and bilateral facial melasma
Exclusion criteria
Exclusion criteria: Pregnant women and breastfeeding mothers Taking oral contraceptive pills during the last 12 months and during the study Existence of any history of coagulation disorders and thrombotic problems Taking Medicines anticoagulants and anticonvulsants Existence of allergy to studied drugs and topical lidocaine History of melasma treatment in the past month Active facial herpes simplex lesions Facial warts
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Melasma area and severeity index score (MASI SCORE). Timepoint: It is done at the beginning of the study and weeks 2, 4, 8 and 12. Method of measurement: Face photography with camera.;Recovery rate of melasma lesions. Timepoint: It is done at the beginning of the study and weeks 2, 4, 8 and 12. Method of measurement: Face photography with camera. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction with melasma treatment. Timepoint: ????????????4 weeks after treatment. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Ahvaz University of Medical Sciences